Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 137.09%9.43K | 104.31%1.92K | -9.06%-79.83K | 64.53%-163.96K | 75.00%-20.82K | 61.63%-25.43K | 75.41%-44.52K | 44.38%-73.19K | -129.18%-462.22K | -76.37%-83.29K |
| Net income from continuing operations | 139.95%31.89K | -122.14%-16.91K | 65.97%-24.9K | 72.03%-154.1K | -166.16%-77.47K | 13.80%-79.83K | 131.64%76.38K | 61.04%-73.18K | 69.21%-550.88K | 90.84%-29.11K |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --46.18K | ---21.86K |
| Other non cashItems | ---- | ---- | ---- | -614.29%-150K | --0 | --0 | ---- | ---- | -101.48%-21K | ---- |
| Change In working capital | -176.40%-22.46K | -35.30%18.83K | -305,044.44%-54.93K | 120.77%140.14K | 820.98%81.65K | 11.63%29.4K | -51.73%29.1K | 99.85%-18 | -63.26%63.48K | -120.77%-11.33K |
| -Change in receivables | 225.07%6.91K | --0 | -67.37%-6.21K | 192.62%20.55K | 378.13%27.3K | -187.97%-5.53K | 175.45%2.49K | 75.86%-3.71K | -160.51%-22.19K | -136.92%-9.81K |
| -Change in prepaid assets | -33.24%502 | --0 | 43.63%-1.25K | 22,324.16%119.57K | 21,642.27%122.41K | 33.57%752 | 96.05%-1.37K | -106.73%-2.22K | -101.58%-538 | 101.40%563 |
| -Change in payables and accrued expense | -187.42%-29.88K | -32.72%18.83K | -902.76%-47.47K | -99.97%23 | -3,181.29%-68.05K | 75.34%34.18K | -71.53%27.99K | 120.04%5.91K | -15.44%86.2K | -103.04%-2.07K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 137.09%9.43K | 104.31%1.92K | -9.06%-79.83K | 64.53%-163.96K | 75.00%-20.82K | 61.63%-25.43K | 75.41%-44.52K | 44.38%-73.19K | -129.18%-462.22K | -76.37%-83.29K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 45K | 0 | 0 | 0 | 0 | 0 | -61.78%120K | |
| Net issuance payments of debt | --0 | --0 | --45K | --0 | --0 | --0 | --0 | --0 | --120K | ---- |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --45K | --0 | --0 | --0 | --0 | --0 | -61.78%120K | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -83.83%15.26K | -90.39%13.35K | -77.29%48.17K | -61.73%212.13K | -60.67%68.99K | -60.93%94.42K | -67.13%138.94K | -61.73%212.13K | 25.41%554.35K | -39.00%175.42K |
| Current changes in cash | 137.09%9.43K | 104.31%1.92K | 52.42%-34.83K | 52.09%-163.96K | -156.71%-20.82K | 61.63%-25.43K | 75.41%-44.52K | 44.38%-73.19K | -404.72%-342.22K | -86.24%36.71K |
| End cash Position | -64.21%24.69K | -83.83%15.26K | -90.39%13.35K | -77.29%48.17K | -77.29%48.17K | -60.67%68.99K | -60.93%94.42K | -67.13%138.94K | -61.73%212.13K | -61.73%212.13K |
| Free cash from | 137.09%9.43K | 104.31%1.92K | -9.06%-79.83K | 64.53%-163.96K | 75.00%-20.82K | 61.63%-25.43K | 75.41%-44.52K | 44.38%-73.19K | -129.18%-462.22K | -76.37%-83.29K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.